Sequani
Kevin Curtis is a seasoned professional in business development within the pharmaceutical and chemical sectors, currently serving as Head of Business Development at Sequani since December 2019. Prior to this role, Kevin held the position of Director of Global Business Development at Scymaris and worked as Key Account Director at Envigo, managing key relationships and expanding service offerings to large pharmaceutical clients. Kevin's extensive experience includes over 18 years at Huntingdon Life Sciences, where roles ranged from Account Director to Divisional Manager, overseeing large teams and ensuring regulatory compliance in laboratory operations. Kevin began their career as a Senior Technician at GSK and holds an HNC in Biochemistry & Animal Technology from the University of Westminster.
This person is not in any teams
Sequani
great people, great work, real results Sequani’s heritage spans more than 40 years when a company called Toxicol Laboratories opened for business in London. A little while later the company moved to the current site in Ledbury’s Bromyard Road. Toxicol Laboratories then joined with Quintiles and the foundations were laid for the company as it is today. The name Sequani dates back to the year 2000 when, after seven years of association with Quintiles, the company changed ownership under a new identity. The name Sequani comes from a Celtic tribe made famous for harrying invading Romans during their suppression of Gaul. We feel the name is apt as we too give the big boys a run for their money! We achieve this by working closely with you to deliver flexible and fast solutions that help keep your development programmes on schedule. Our customer feedback consistently shows that the service and commitment our clients enjoy is the most personal and direct in the business. But we take none of this for granted. Our focus is continuous improvement so that we carry on growing through the repeat business of loyal customers as well as attracting business from new clients.